Status:
COMPLETED
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
Lead Sponsor:
AstraZeneca
Conditions:
Bronchial Asthma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Eligibility Criteria
Inclusion
- Patients treated with Symbicort for the first time possibly at the higher dose due to bronchial asthma
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01232335
Start Date
January 1 2010
End Date
May 1 2013
Last Update
May 29 2013
Active Locations (47)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aichi, Japan, Japan
2
Research Site
Akita, Japan, Japan
3
Research Site
Aomori, Japan, Japan
4
Research Site
Chiba, Japan, Japan